NCT01754025View on ClinicalTrials.gov

INHERIT EGFR - Studying Germline EGFR Mutations

Active, not recruitingOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

December 28, 2012

Primary Completion Date

November 7, 2018

Study Completion Date

December 31, 2029

Conditions
Lung Cancer
Trial Locations (2)

37232

Vanderbilt-Ingram Cancer Center, Nashville

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Addario Lung Cancer Medical Institute

OTHER

lead

Dana-Farber Cancer Institute

OTHER